SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-004119
Filing Date
2021-02-10
Accepted
2021-02-10 16:42:33
Documents
13
Period of Report
2021-02-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10020074_8-k.htm   iXBRL 8-K 34584
  Complete submission text file 0001140361-21-004119.txt   224593

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmy-20210210.xsd EX-101.SCH 5017
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20210210_def.xml EX-101.DEF 18572
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20210210_lab.xml EX-101.LAB 28668
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20210210_pre.xml EX-101.PRE 20872
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10020074_8-k_htm.xml XML 8448
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 21614585
SIC: 2834 Pharmaceutical Preparations